Perspective Therapeutics (CATX) FCF Payout Ratio (2015)

Perspective Therapeutics' (CATX) quarterly FCF Payout Ratio came in at 0.0 in Q2 2015.

Perspective Therapeutics (CATX) FCF Payout Ratio (2015) Analysis & Trends

Perspective Therapeutics has disclosed FCF Payout Ratio across 1 years of filings, most recently posting 0.0 for Q2 2015.

FCF Payout Ratio for Q2 2015 came in at 0.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2017 was 0.0 (changed N/A YoY), and the FY2021 annual result was 0.0, changed 0.49% from the prior year.
FCF Payout Ratio came in at 0.0 for Q2 2015 at Perspective Therapeutics.
In the past five years, FCF Payout Ratio ranged from a high of 0.0 in Q2 2015 to a low of 0.0 in Q2 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	1.20
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.81
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.40
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.08
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.25
10	Perspective Therapeutics	308.74 Mn	308.74 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2015	0.00